WASHINGTON

Anthropic shares fell 10 percent in premarket trading Friday as Washington intensified its focus on regulating artificial intelligence development. The decline signals investor concern about the company's near-term prospects during accelerating congressional scrutiny and a Trump administration that is balancing calls for U.S. AI dominance with demands for federal guardrails.

Senator Chuck Schumer is leading bipartisan efforts to draft comprehensive AI legislation, convening multiple forums with industry leaders and academic experts. Congressional committees are holding extensive hearings on AI safety, competition and ethical development. The timing of Anthropic's stock drop could accelerate these legislative efforts, particularly if lawmakers interpret the market move as evidence that industry confidence is fragile.

The broader market declined sharply—the Nasdaq fell 2.3 percent and the S&P 500 dropped 2.0 percent—suggesting the selloff reflects wider investor caution rather than concerns unique to Anthropic. Still, a prominent AI developer's stumble may embolden regulators and consumer advocates already pushing for stricter rules.

AI companies have ramped up lobbying spending in Washington to shape emerging regulations and secure favorable outcomes. A perceived weakening in market confidence for a leading firm could shift political leverage away from industry groups and toward regulators demanding tougher oversight.

The National Institute of Standards and Technology, under the Department of Commerce, is expected to release preliminary AI risk management guidelines next month. Those guidelines, initially voluntary, could become the foundation for future legislation and set new competitive standards for companies like Anthropic.